Abiopharma

🔍 Carpenter Rick (Executive)

Company: TANDEM DIABETES CARE INC (TNDM)

Report Date: 2025-12-15

Detailed Transactions and Holdings:

• Acquired 406 shares of Common Stock (Direct)
  Date: 2025-12-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 24,459.00 | transaction_form_type: 4
• Sold 207 shares of Common Stock at $22.11 per share (Direct)
  Date: 2025-12-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 24,252.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 406 shares of Restricted Stock Unit (Derivative)
  Date: 2025-12-15 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3, F4, F4

Footnotes:

• F1: Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
• F2: Awarded on December 15, 2021 pursuant to the Tandem Diabetes Care Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
• F3: RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
• F4: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 12/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.